The present study aimed to produce and pathophysiologically evaluate the metallothionein (MT) fusion protein. A recombinant plasmid containing DNA segment coding the pET-glutathione transferase (GST)-small ubiquitin-related modifier (SUMO)-MT fusion protein was inserted into Escherichia coli for expression. The expression level of the fusion protein was very high, reaching to 38.4% of the total supernatant proteins from the organism. Subsequent filtration through glutathione Sepharose 4B gel and Sephadex G-25 yielded an MT fusion protein with purity more than 95%. When exposed to metals, E. coli containing the GST-SUMO-MT fusion protein showed an increased accumulation of Cd 2ϩ , Zn 2ϩ , or Cu 2ϩ at approximately 4.2, 4.0, or 1.6 times higher, respectively, than those containing the control protein. Administration of GST-SUMO-MT to mice that were also treated with D-galactose to induce neuronal and hepatic damage showed a significant improvement of animal learning and memory capacity, which was depressed in mice treated by D-galactose alone. Administration of MT fusion protein also prevented D-galactose-increased malondialdehyde contents and histopathological changes in the brain and liver. Furthermore, supplement of the fusion protein significantly prevented D-galactose-increased nitric oxide contents and -decreased superoxide dismutase activity in the brain, liver, and serum. The fusion protein was also able to prevent ionizing radiation-induced DNA damage of the mouse thymus. The present study indicates that GST-SUMO-MT has a normal metal binding feature and also significantly protects the multiple tissues against oxidative damage in vivo caused by chronic exposure to Dgalactose and by ionizing radiation. Therefore, GST-SUMO-MT may be a potential candidate to be developed for the clinical application.
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Metallothioneins (MTs) are a group of cysteine-rich proteins that ubiquitously present in the tissues of animals, plants, and microorganisms (Vasá k, 2005) . MTs have highly conserved primary structures and similar spatial conformations. In mammals, four isoforms of MT exist: MT-I and MT-II are present in all tissues, whereas MT-III and MT-IV are present in brain tissues and keratinized epithelium, respectively (Theocharis et al., 2003; Vasá k, 2005) . MTs not only are able to bind heavy metal ions and modulate trace mineral balance but are also able to protect tissues and cells from oxidative damage via scavenging various free radicals (Cai et al., 2004 (Cai et al., , 2005 (Cai et al., , 2006 Penkowa et al., 2004 Penkowa et al., , 2005 Fang et al., 2006; Yang et al., 2006) . In this regard, MTs have been considered as a target for the development of drugs (Jacob et al., 2000; Vasá k, 2005; Li et al., 2006; Cai, 2007) .
Mammals or yeasts have been used to produce MTs (Vasá k, 2005 ), but Escherichia coli should be the preferred host organism for production of specific proteins because E. coli expression systems have several advantages, including high expression rate, easy cultivation and manipulation, and low cost. To date, there remains no study using E. coli to produce large amounts of soluble MT, mainly because of the small molecular mass of MTs (Butt et al., 1989; Zhou et al., 2000; Hong et al., 2001 ). In addition, MTs have toxic effects on the host strains and inhibit their growth because of the existence of more than 20 sulfhydryl groups in its amino acid composition (Butt et al., 1989; Zhou et al., 2000; Hong et al., 2001) . To overcome this difficulty, researchers have utilized fusion technology, creating fusions of the MT genes with chaperones such as glutathione transferase (GST), ubiquitin, and intein to assist in correctly folding the protein (Butt et al., 1989; Zhou et al., 2000; Hong et al., 2001; Yang et al., 2007) . Although protein solubility and yield have increased (the highest amount obtainable is 8 mg/l), the procedure remains having several disadvantages, which include the frequent formation of inclusion bodies, time consumption, high cost because of the large amount of proteases, and high rate of mistaking target protein hydrolysis by proteases.
The primary structures of small ubiquitin-related modifier (SUMO) and ubiquitin are only 18% homologous, but their tertiary structures and some biological functions are very similar (Herrmann et al., 2007) . SUMO ubiquitously exits in most eukaryotic cells and participates in many physiological processes, including apoptosis, signal transduction, RNA transcription, nucleocytoplasmic protein transport, and cell cycle regulation (Herrmann et al., 2007; Kerscher, 2007) . SUMO has been used recently as a fusion tag in recombinant protein expression. This technique processes the antiproteolytic property that significantly increases recombinant protein expression levels, correctly facilitates target protein folding, and increases protein solubility (Butt et al., 2005; Su et al., 2006) .
In the present study, therefore, we used GST and SUMO as tags to fuse the human MT-I gene and induced its expression in E. coli. The objectives were: 1) to use the two molecular chaperones to enhance human MT-I protein expression and solubility and to facilitate its correct folding, 2) to assess the ability of MT-fusion protein to bind heavy metal ions, and 3) to evaluate the biological activity of this fusion protein in neuronal and hepatic protection against D-galactose-and ionizing radiation-induced damage in a mouse model.
Materials and Methods
Reagents. The plasmid pGEX-4T-3 and E. coli strains DH5␣ and Origami (DE3) were obtained from Jinan Biopharmaceutical Research and Development Center (Guongzhou, China). The expression vector pET-28a was purchased from Novagen (Madison, WI). The Pyrobest DNA polymerase, dNTP (each 2.5 mM), T 4 DNA ligase, restriction enzymes (NdeI, XhoI, and BamHI), DNA Marker (DL-15,000), Minibest Plasmid Purification Kit, and DNA Fragment Purification Kit were obtained from Dalian Takara Corp. (Dalian, China). The Glutathione Sepharose 4B and Sephadex G-25 gels were purchased from GE Healthcare (Chalfont St. Giles, UK). Rabbit anti-GST monoclonal antibody was purchased from Wuhan Boster Bioengineering Ltd. (Wuhan, China). D-Galactose, vitamin E, and CdCl 2 were purchased from Sigma-Aldrich (St. Louis, MO). Kits for measurements of malondialdehyde (MDA), nitric oxide (NO), and superoxide dismutase (SOD) were all purchased from the Institute of Nanjing Jiancheng Biotechnology (Jiangsu, China).
Construction of the pET-GST-SUMO-MT Recombinant Plasmid. Yeast mature SUMO peptide sequences (NC_001136.8) and human MT-IA nucleic acid sequence (NC_000016.8) were obtained from the National Center for Biotechnology Information database. DNAStar PrimerSelect software was used to design 15 primer sequences based on codon usage bias in E. coli (Table 1) . The primers were synthesized by Shanghai Sangon Biological Engineering Technology and Services Co., Ltd. (Shanghai, China). Bridge polymerase chain reaction (PCR) (Fig. 1A ) was used to obtain the DNA segment coding GST-SUMO-MT fusion protein. This segment was then cloned into the prokaryotic expression vector pET-28a to obtain the recombinant plasmid pET-GST-SUMO-MT. The control plasmid pET-GST-SUMO was also obtained by the above method. These two plasmids were transformed into E. coli Origami (DE3) cells. The recombinant transformants were selected by kanamycin resistance, and sequencing was performed by Shanghai Sangon Biological Engineering Technology and Services Co., Ltd. The structures of the two proteins are shown in Fig. 1B .
The Expression and Solubility Analysis of Fusion Protein. Recombinants were inoculated in fresh Luria-Bertani (LB) medium, and incubated at 37°C on an orbital shaker (220 rpm) overnight. at ASPET Journals on July 10, 2017 jpet.aspetjournals.org
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Each sample was then inoculated into 200 ml of fresh medium with a ratio of 1:20 and incubated in a shaking incubator at 37°C until the OD 600 was 1.0 to 1.2. All liquid culture was scaled up to 3 liters of LB medium and incubated until OD 600 was 8 to 10. Then, isopropyl ␤-D-thiogalactoside (IPTG; Promega, Terso Solutions, Inc., Madison, WI) was added at a final concentration of 1 mM for the induction of expression at 20°C for 20 h. Bacterial cells were collected by centrifugation and lysed by sonication. The supernatants and pellets were collected and subjected to 12% SDS-polyacrylamide gel electrophoresis (PAGE) analysis. Electrophoretic results were analyzed by thinlayer gel scanning. Fusion Protein Purification. Glutathione Sepharose 4B gel columns were equilibrated using three column volumes of phosphate-buffered saline (PBS), pH 7.4. Sample loading was then performed at a flow rate of approximately 1 ml/min. The columns were then washed with three column-volumes of PBS. Finally, 50 mM Tris-HCl buffer, pH 7.4, containing 20 mM glutathione was used to elute the target protein, and eluted fractions were collected and then desalted using Sephadex G-25 resin. The final concentrations of eluted GST-SUMO-MT and GST-SUMO solutions were 0.6 and 0.84 mg/ml and were further concentrated by lyophilization.
Measurement of Divalent Metal Ion Accumulation in Recombinant E. coli by Atomic Absorption Spectrometry. Different groups of E. coli containing the recombinant plasmid pET-GST-SUMO-MT, pET-GST-SUMO, or the empty vector pET-28a were inoculated separately on LB medium and incubated at 37°C in a shaker incubator overnight. Each sample was then transferred to fresh LB medium to a final concentration of 2% and incubated in a shaker incubator until OD 600 ϭ 0.8. IPTG was then added at a final concentration of 1 mM, along with different divalent metal ions (700 M Cd 2ϩ , 3.5 mM Cu 2ϩ , or 1.5 mM Zn 2ϩ ). After expression of the fusion protein was induced with 1 mM IPTG for 20 h, cells were collected by centrifugation, washed three times using precooled LB medium, and weighed. Cells were digested in 60% nitric acid solution at a final concentration of 10 mg/ml. The digested solution was diluted five times to be used for atomic absorption spectrometry analysis. The measurements were repeated three times.
Measurement of the Cd 2؉ Binding Ability of GST-SUMO-MT Fusion Protein and by Bovine Hemoglobin Saturation. Cadmium binding ability of GST-SUMO-MT was evaluated based on the cadmium hemoglobin saturation (Cd-hem) assay (Law and Stillman, 1984) . One hundred microliters of 3 M GST-SUMO-MT protein solution was mixed with 400 l of 10 mM Tris-HCl, pH 8.6, and 100 l of 7 mM CdCl 2 solution and 5 min later with 200 l of 2% bovine hem solution (w/w). The mixture was incubated at room temperature for 10 min, heated in a boiling water bath for 2 to 3 min, and centrifuged at 12,000 rpm (13,201g) for 10 min. The supernatants were collected, mixed with 100 l of 2% bovine hemoglobin solution, and then the above processes of incubation, heating, and centrifugation were repeated for collecting the supernatants. The Cd 2ϩ content in the supernatants was measured using atomic absorption spectrometry. The measurements were repeated three times.
The following equation was used to calculate the cadmium binding ability of the fusion protein:
where n is the number of metal ions bound by fusion protein.
Mouse Model for D-Galactose-or Ionizing Radiation-Induced Damage. Seventy-two healthy Kunming mice (36 males and 36 females), 20 Ϯ 2 g, were randomly divided into seven groups (n ϭ 12, six males and six females): control group, D-galactose group, D-galactose/GST-SUMO-MT group in which D-galactose plus GST-SUMO-MT protein at three doses levels (see the below for detail), antioxidant group (D-galactose/vitamin E), and D-galactose/GST-SUMO group. The D-galactose group was given a daily intraperitoneal injection of D-galactose (150 mg/kg body weight) for 8 weeks, based on previous studies showing that D-galactose at either 100 mg/kg daily or 200 mg/kg induced same effect on neuronal damage (Wei et al., 2005; Cui et al., 2006; Zhang et al., 2007) . The control group was given a daily intraperitoneal injection of the same volume of saline. The three GST-SUMO-MT dose levels in the D-galactose/ GST-SUMO-MT group are high (7 mg/kg or 156.67 nmol/kg), medium (3 mg/kg or 67.14 nmol/kg), and low (1.5 mg/kg or 33.57 nmol/ kg) daily and indicated by GST-SUMO-MT-H, GST-SUMO-MT-M, and GST-SUMO-MT-L, respectively. As a negative control of GST-SUMO-MT, GST-SUMO at 7 mg/kg (181.51 nmol/kg) also was given daily to the mice treated with D-galactose. As an antioxidant control group, mice were given vitamin E subcutaneously at 60 mg/kg (139.3 mol/kg) daily simultaneously with the administration of D-galactose. The lyophilized GST-SUMO-MT and GST-SUMO were dissolved in PBS as stock solutions (5 mg/ml) and diluted to appropriate concentrations as needed in a final of 100 l of PBS solution, respectively. GST-SUMO-MT, GST-SUMO, vitamin E, and saline all were given by subcutaneous injection with equal volume of solution (100 l).
For the ionizing radiation study, mice were irradiated in whole body with 7 Gy of 60 Co ␥-rays at a dose rate of 1.743 Gy/min. This study included seven groups same as the above grouping. However, GST-SUMO-MT at the aforementioned three dose levels, GST-SUMO at 7 mg/kg, and vitamin E at 7 mg/kg were subcutaneously given 1 h before irradiation, and mice were sacrificed at 6 h after irradiation.
Water Maze Experiment. After 8 weeks of D-galactose administration, mice from all groups were given water maze experiments for leaning and memory evaluation according to the previous reports (Xu et al., 2001; Wei et al., 2005) with certain modifications. In brief, the water maze was made up of black organic glass with four connective spaces, four dead ends, and one escape platform. The water maze was immersed in 10-cm-depth water at 25 Ϯ 2°C. Before the first trial, each mouse was put on the platform for 15 s, and then the mouse was given a 30-s free swim and assisted to the platform, where it remained for another 15-s rest. After three times of training, the record was taken; the mouse was released into the most inner space of the water maze for free swim to find the escape platform, and the swim time and error times were recorded. The process of water maze experiment consisted of 4-day learning and memory training and the performance on the 5th day was recorded as learning capability and on the 6th day or later as memory capability. 
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Detection of Brain MT Contents. Brain MT contents were measured from the brain tissues of radiated mice with and without GST-SUMO-MT, GST-SUMO, or vitamin E by Cd-hem saturation assay using atomic absorption spectrometry, as described above and also in our previous study (Cai et al., 2004) .
Detection of MDA, NO, and SOD. Measurements of MDA by 2-thiobarbituric acid method, NO by nitrate reductase method, and SOD activity by xanthine oxidase method were performed, respectively, based on their kit instructions. In brief, blood was obtained, and serum was prepared. Mouse brain tissue or liver tissue was homogenized to obtain the supernatant. Protein concentrations were determined by the Coomassie Brilliant Blue method. Subsequently, serum and tissue contents of MDA and NO and SOD activity were measured. MDA content was expressed as nanomoles of MDA per milligram of protein for tissues or milliliters for serum. Brain and liver tissues were prepared as 10% (w/v) homogenate for NO content evaluation, and the content of NO was expressed as micromoles of NO per liter of tissue homogenate or serum. The activity of SOD was expressed as enzymatic activity (units) per milligram of protein for tissue or milliliters for serum.
Pathological Examination of Brain and Liver Tissues. Brain and liver tissues from each mouse were collected, fixed by immersing in 10% formalin, and processed into paraffin sections (5-m thickness). Sections were stained by hematoxylin and eosin and examined under light microscopy for the pathological changes in CA1 region neurons of the hippocampus and hepatocytes of the liver.
Immunohistochemical Staining for MT. Expression of MT in the brain was examined by immunohistochemical staining with monoclonal mouse anti-MT antibody (Zymed Laboratories, South San Francisco, CA). After deparaffinization and redehydration, the slides with brain tissues were quenched for endogenous peroxidase activity by 3% H 2 O 2 for 10 min at room temperature. Nonspecific binding sites were blocked by 5% normal rabbit serum for 30 min. Then, MT staining was performed based on our published method (Cai et al., 2004) .
Thymus Genomic Isolation and Electrophoretic Analysis on Agarose Gel. DNA from thymus of mice irradiated with and without preadministration of MT fusion protein, vitamin E, or GST-SUMO protein was isolated as described in our previous study (Cai et al., 1997) and quantified with spectrophotometry at 260 nm. An aliquot of DNA (10 g) from each sample was fractionated through 2% agarose gels (50 -60 V, 3.5 h). After electrophoresis, gels were stained with ethidium bromide, and the DNA electrophoretic patterns were imaged.
Statistical Analysis. All data are expressed as mean Ϯ S.D. SPSS software (version 10.0; SPSS Inc., Chicago, IL) was used for the analysis. Mean value comparisons between two groups were performed using the Student's t test, and mean value comparisons between multiple groups were performed using one-way analysis of variance, followed by post hoc multiple comparisons. Significant difference was considered at p Ͻ 0.05.
Results
PCR Amplification of the DNA Segment Coding GST-SUMO-MT Fusion Protein. Bridge PCR was used with the 15 synthesized primers (Table 1) to generate the DNA segment coding GST-SUMO-MT fusion protein, as outlined in Fig. 1A . The segment was cloned into the pGEX-4T-3 expression vector, resulting in the recombination plasmid pGEX-GST-SUMO-MT (Fig. 1B) . The plasmid was used as a template, with GF1 and MR1 as upstream and downstream primers to amplify the DNA segment coding GS-MT fusion protein. The segment, which had a predicted size of approximately 1221 bp ( Fig. 2A) , was inserted into the pET-28a expression vector, resulting in the recombinant plasmid pET-GST-SUMO-MT, for expression in host bacteria [E. coli Origami (DE3)]. The recombinant plasmid was sequenced, and the sequence of the positive recombinant was found to be identical to the predicted sequence (data not shown).
Induction of Fusion Protein Expression, Isolation, and Purification. After induction by IPTG at 20°C for 20 h, cells were sonicated, and the resulting lysate was centrifuged [18,000 rpm (29,703g) ] at 4°C for 30 min. Analysis of the supernatant and pellet using 12% SDS-PAGE showed that the GST-SUMO-MT fusion protein (molecular mass, 43 kDa) was mainly expressed in soluble form and composed 38.4% of total supernatant protein (Fig. 2B) . Glutathione Sepharose 4B gel columns and Sephadex G-25 molecular filters were used to isolate and purify GST-SUMO-MT fusion protein. SDS-PAGE gel electrophoresis and thin-layer gel scanning analysis revealed a target band protein (approximate molecular mass, 43 kDa) in the eluant, with a purity of more than 95% (Fig. 2C) . Table 2 is the summary of the fusion protein isolation and purification. Furthermore, Western blot analysis showed that the fusion protein reacted positively with the anti-GST monoclonal antibody (Fig. 2D) .
Analysis of the Divalent Metal Binding Ability of MT Fusion Protein in Vivo. E. coli containing the recombinant plasmid pET-GST-SUMO-MT, pET-GST-SUMO, or the empty vector pET-28a were inoculated on LB medium, and then expression of these proteins was induced by adding 1 mM IPTG with the presence of 700 M Cd 2ϩ , 1.5 mM Zn 2ϩ , or 3.5 mM Cu 2ϩ . Analysis by atomic absorption spectrometry showed that E. coli containing GST-SUMO-MT significantly increased the accumulation of cadmium or zinc after expo- sure to either metal (Fig. 3) . The concentrations of these two ions were approximately 4.2 and 4.0 times, respectively, higher than that of controls (Fig. 3) , although E. coli containing GST-SUMO-MT protein could also retain an increased Cu 2ϩ level but not significantly differ from controls (Fig. 3) .
To evaluate the cadmium binding ability of GST-SUMO-MT, the cadmium saturation assay was performed and revealed that the mean concentration of Cd 2ϩ bound to GST-SUMO-MT and GST-SUMO was 7.855 ϫ 10 Ϫ6 and 1. (Fig. 4, A and B) . Normal mice took approximately 30 to 40 s to complete the whole swimming process, whereas D-galactose-treated mice took approximately 90 s to complete the whole process of either learning or memory swimming (Fig. 4, A and B) . Treatment of Dgalactose-treated mice with vitamin E provided a significant attenuation of D-galactose-suppressed learning and memory capacities (Fig. 4, A and B) . Administration of D-galactosetreated mice with the purified GST-SUMO-MT proteins also showed attenuating D-galactose-suppressed learning and memory capacity in a dose-dependent manner (Fig. 4, A  and B) .
D-Galactose treatment significantly increased incidence of swimming mistakes, which was also prevented by administration of either vitamin E or GST-SUMO-MT fusion protein (Fig. 4, C and D) . It is more interesting that the protective effects of MT at the high concentration (7 mg/kg daily) are comparable with those of vitamin E (60 mg/kg daily), suggesting the remarkable efficiency of GST-SUMO-MT fusion protein compared with vitamin E in protecting D-galactoseinduced neurological dysfunction. To further characterize the protective effect of MT fusion protein against D-galactose-induced neurological damage, tissues of the brain were evaluated by morphological examination and biochemical measurement of oxidative damage (MDA). Morphological examination of the hippocampus CA1 region with light microscope by hematoxylin and eosin staining showed that compared with the control group, D-galactose treatment caused significant increases in pathological changes, including disorganized nerve fibers with markedly tangled, irregular, and pyknotic nuclei of neurons and the apoptosis-like cells with marginated, condensed, and darkly stained and even vacuolated chromatin (Fig. 5A, b) . In the group treated with the high dose of GST-SUMO-MT, the hippocampus CA1 region displayed neurons with a mostly round shape, areas of dark staining, nerve fibers without significant tangling (Fig. 5A, d ), which was similar to those of vitamin E treatment group and control group (Fig. 5A , a and c), but treatment with middle or low dose of GST-SUMO-MT showed relatively less protective effects (Fig. 5A, e and f) , whereas in the group treated with GST-SUMO, neurons were loosely arranged and had pyknotic nuclei and indistinct nucleoli (data not shown).
To quantitatively analyze the brain damage, MDA contents in brain were measured as an index of oxidative damage. After 8-week D-galactose treatment, brain MDA content was increased approximately two times compared with the control mice (Fig. 5C ). There was a dose-dependent response for the protective effects of GST-SUMO-MT against D-galactose-induced MDA levels. It is important that the protective effect of GST-SUMO-MT at 7 mg/kg daily is similar to that of vitamin E at 60 mg/kg daily (Fig. 5C ). There was no difference for the MDA contents between D-galactose-treated groups with and without GST-SUMO (Fig. 5C , p Ͼ 0.05), suggesting the protective effect of MT in GST-SUMO-MT fusion protein in the brain against D-galactose-induced oxidative damage.
Because MT is inducible by various stresses, we next performed immunohistochemical staining MT with anti-MT antibody to determine whether the neuronal protection observed above is attributed to the administered GST-SUMO-MT fusion protein, rather than induced MT. Mice were given saline (control), GST-SUMO-MT fusion proteins at the aforementioned three dose levels, GST-SUMO protein A, GST-SUMO-MT; B, GST-SUMO. 
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at ASPET Journals on July 10, 2017 jpet.aspetjournals.org at 7 mg/kg, and vitamin E (7 mg/kg). One hour after administration of these reagents, mice were irradiated in whole body with 7-Gy ␥-rays. Six hours after irradiation, mice were sacrificed to investigate the MT distribution in the brain. There was no obvious MT staining in the brain of control (Fig.  6A ). Exposure to radiation significantly increased MT staining, and the positive staining was predominantly distributed in the nuclei or perinuclei (Fig. 6B) , suggesting the induction of intracellular MT. In contrast, mice with administration of GST-SUMO-MT fusion proteins before radiation showed a significant increase in positive MT staining diffused in the brain tissue in a manner of dose-dependent of administered GST-SUMO-MT without the significant increase of nuclear or perinuclear MT staining (Fig. 6, C-E) . This finding suggests that the administered GST-SUMO-MT attenuates radiation-induced intracellular MT synthesis. Administration of GST-SUMO protein did not increase the diffused MT staining but showed the induction of intracellular MT by radiation (Fig. 6F) , whereas administration of vitamin E did not cause the diffused MT staining or did not significantly induce intracellular MT synthesis (Fig. 6G) , probably because of its prevention of radiation-induced MT induction.
To quantitatively analyze MT expression, brain MT contents were measured by Cd-hem saturation assay (Fig. 6H) , showing that radiation increased brain MT contents, as shown by immunochemical staining (Fig. 6B) , and high and middle doses of GST-SUMO-MT further increased brain MT contents, whereas low dose of GST-SUMO-MT, GST-SUMO, and vitamin E did not further increased radiation-induced MT contents, as shown by staining results (Fig. 6, C-G) .
It is known that toxic effects of D-galactose treatment may not be only in the brain but also in other organs. To evaluate whether administered MT fusion protein also protects other organs from D-galactose-induced damage, the toxicity of Dgalactose and the protection of MT fusion protein were also evaluated by examination of hepatic morphology and measurements of hepatic and serum MDA contents. Again, Dgalactose treatment induced significantly morphological changes in the liver (Fig. 5B, b ) and significant increases in hepatic and serum MDA contents (Fig. 5C ), but all these effects of D-galactose in the liver and serum were significantly prevented by vitamin E and the GST-SUMO-MT fusion protein but not the GST-SUMO protein. Goffe et al., 1999; Kowluru and Koppolu, 2002; Ellis et al., 2005) . This is also supported by the present study that vitamin E significantly protected D-galactose-induced damage. D-Galactose-caused oxidative damage to the tissue has been attributed to overgeneration of the most reactive species peroxynitrite because of overgeneration of NO and superoxide (Le Goffe et al., 1999; Kowluru and Koppolu, 2002; Ellis et al., 2005) . Consistent with these early studies, 8-week treatment with D-galactose significantly increased NO contents in the brain, liver, and serum, i.e., approximately 2.1, 3.3, and 3.9 times higher than those of controls (Fig. 7A) . Administration of GST-SUMO-MT protein showed a dose-dependent protection against D-galactoseinduced increase in NO in the tissues and serum.
Possible Mechanisms for GST-SUMO-MT Fusion Protein to Protect the Brain and Liver against D-Ga
Increased NO may interact with superoxide to form peroxynitrite that has been considered as the strongest free radical involved in several pathogenesis, including aging and diabetic complications. Superoxide is dismutated by SOD; therefore, if tissue SOD activity decreases, there will be a possibility for the increased superoxide to interact with NO to form peroxynitrite. SOD activities in the liver, brain, and serum were significantly decreased in the mice treated with D-galactose to the extent of 42, 56, and 54%, respectively, of that in the tissues and serum of the control group (Fig. 7B) . The high dose of GST-SUMO-MT protein restored SOD activity in the brain, liver, and serum (p Ͻ 0.01), an effect comparable with the protection of vitamin E. In contrast, GST-SUMO-MT protein at the middle dose restored SOD activity only in the liver (p Ͻ 0.05) but at the low dose has no therapeutic effect. The group treated with GST-SUMO showed only slight restoration of SOD activity in the liver, but not in the brain and serum (Fig. 7B ). at ASPET Journals on July 10, 2017 jpet.aspetjournals.org
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Based on the above findings, a question to be answered is whether the protection of administered MT fusion protein is attributed to the reduction of D-galactose absorption via a possible interaction of GST-SUMO-MT with D-galactose. To avoid such possibility and also directly define the antioxidant of GST-SUMO-MT fusion protein in vivo, mice were administered with GST-SUMO-MT protein and 1 h later irradiated in whole-body ionizing radiation because ionizing radiation is a well known challenge to directly penetrate tissues and ionize water to produce various free radicals (Cai et al., 2004) . After whole-body irradiation, mouse thymuses from different groups of mice were collected to isolate the genomic DNA. Agarose gel electrophoresis showed that ionizing radiation caused a significant increase in DNA fragmentation, shown by smear DNA (Fig. 8, lane 1) . Preadministration of GST-SUMO-MT fusion proteins and vitamin E significantly protected radiation-induced DNA damage (Fig. 8, lanes 2-4 for GST-SUMO-MT proteins and lane 5 for vitamin E), whereas preadministration of GST-SUMO protein did not have any protective effect (Fig. 8, lane 6) . This finding that GST-SUMO-MT is able to directly protect DNA against radiation-induced oxidative damage suggests that GST-SUMO-MT protects D-galactose-induced oxidative damage may not be predominantly mediated, at least by its direct interaction with D-galactose.
Discussion
Because MTs have the features of small molecular mass and are cysteine-rich, MTs are difficult to be produced directly by using genetic engineering methods. No matter whether yeast or E. coli was used for this purpose, expression levels are extremely low (Butt et al., 1989; Zhou et al., 2000; Hong et al., 2001; Yang et al., 2007) . Although fusion expression methods have greatly increased MT protein solubility and expression levels, monomeric MT yield was significantly lower than the polymer MTs (Hong et al., 2001; Yang et al., 2007) . In recent years, SUMO has been found to increase heterogeneous protein expression levels and solubility as a molecular chaperone (Butt et al., 2005) . Furthermore, SUMO protein was also found to increase fusion protein solubility by providing a highly hydrophobic core that acts as a nucleation site for target protein folding, promoting interactions between proteins and their correct folding (Butt et al., 2005; Herrmann et al., 2007; Kerscher, 2007) . The present study presents the evidence, for the first time, that MT can be highly expressed in E. coli using GST and SUMO concurrently as fusion tags to produce a large amount of soluble fusion proteins (approximately 38.4% of total protein of the organism). After purification, the GST-SUMO-MT protein purity exceeded 95% and reached to a yield as approximately 70 mg/l. Mammalian MT molecules were reported able to bind seven Cd 2ϩ ions (Robbins et al., 1991) . Our study found that the fusion protein could only bind two to three Cd 2ϩ ions or two to three other divalent metal ions (Zn 2ϩ and Cu 2ϩ ). The reason is currently unknown and needs further investigation. One of the possibilities is that the lower ion binding ability of the MT fusion protein might be due to physical obstruction by the molecular chaperone (Ferrer Soler et al., 2003) , preventing metal ions from binding to MTs.
Besides the capacity of metal binding, MT acts as a potent antioxidant to protect tissues in vivo and cells in vitro against oxidative damage under different conditions (Cai et al., 2004 (Cai et al., , 2005 (Cai et al., , 2006 Penkowa et al., 2004 Penkowa et al., , 2005 . Animals chronically exposed to D-galactose have been extensively used to investigate the damage related to aging and diabetic complications (Le Goffe et al., 1999; Kowluru and Koppolu, 2002; Ellis et al., 2005; Ramana et al., 2006; Kador et al., 2007) . Although D-galactose is not a well known chemical to produce oxidative stress, chronic exposure to D-galactose indeed caused significant increases in oxidative damage such as MDA and decreases in antioxidants, such as SOD, catalase, and glutathione peroxidase (Ramana et al., 2006; Lu et al., 2007) . We also found that MDA levels and SOD activities were significantly increased and decreased, respectively, in the brain, liver, and serum, which is accompanied by a significant increase in histopathological abnormality. To support the induction of oxidative damage by D-galactose, we found the complete prevention of preadministered vitamin E against D-galactose-induced various damages, which is also consistent with previous studies (Cui et al., 2006; Ramana et al., 2006; Lu et al., 2007) . Furthermore, we provide the first evidence that administration of the MT fusion protein can effectively prevent the pathogenic changes caused by chronic D-galactose treatment in the mouse model. However, high concentrations of GST-SUMO protein used as control had no protective effect on D-galactose-induced MDA increase and NO overproduction in the brain, liver, and serum, demonstrating that MT in the fusion protein plays a key role in protecting these multiple tissues from oxidative damage. In addition, the significant protection of preadministration of MT fusion protein against radiation-induced DNA damage in the mouse thymus also directly indicates the antioxidant of MT fusion protein against the chronic D-galactose-or radiation-induced oxidative damage.
GST-SUMO-MT and Its in Vivo Antioxidant
It is most interesting that the protective effectiveness of MT fusion protein at 7 mg/kg daily is the same as vitamin E at 60 mg/kg daily. Given that GST-SUMO-MT molecular mass is approximate 100 times of vitamin E (44,680.77/ 430.72 g/mol ϭ 103.7), the effectiveness of GST-SUMO-MT is approximately 889 times of vitamin E (60/7 ϫ 103.7 ϭ 888.9). This is consistent with the previous in vitro studies showing the extraordinary efficiency of MT in scavenging various free radicals compared with other antioxidants (Thornalley and Vasá k, 1985; Abel and de Ruiter, 1989; Quesada et al., 1996; Cai and Cherian, 2003) . For instance, MT containing zinc and/or cadmium was shown to scavenge hydroxyl and superoxide radicals produced by the xanthine/xanthine oxidase reaction system (Thornalley and Vasá k, 1985) . The rate constant of the reaction of hydroxyl radical with MT (K. OH/MT ϭ 2700) is approximately 340-fold higher than that with GSH (K. OH/GSH ϭ 8) (Thornalley and Vasá k, 1985) . Other studies have shown that MT is approximately 800-fold more potent than GSH (on a molar basis) in preventing hydroxyl radically generated DNA degradation in vitro (Abel and de Ruiter, 1989) . Because native MT is unstable, there was no informa- Mice were irradiated with whole-body radiation of 7 Gy with 60 Co X-rays with and without 1-h preadministration of MT fusion protein, vitamin E, and GST-SUMO (n ϭ 10). Six hours after radiation, mice were sacrificed to collect the brain for immunohistochemical staining with anti-MT specific antibody (A-G) and for MT content by Cd-hem saturation assay (H). A, control; B, radiation (7 Gy); C, GST-SUMO-MT-H (7 mg/kg or 156.67 nmol/kg)/radiation; D, GST-SUMO-MT-M (3 mg/kg or 67.14 nmol/kg)/radiation; E, GST-SUMO-MT-L (1.5 mg/kg or 33.57 nmol/kg)/radiation; F, GST-SUMO (7 mg/kg or 181.5 nmol/kg)/radiation; G, vitamin E (7 mg/kg or 16.25 mol/kg)/radiation. ##, p Ͻ 0.01 versus control; ‫,ء‬ p Ͻ 0.05 versus radiation. (Thornalley and Vasák, 1985; Abel and de Ruiter, 1989; Quesada et al., 1996; Cai and Cherian, 2003) . For the first time, the present study provides in vivo evidence that the MT fusion protein has such high efficiency in preventing oxidative damage caused by D-galactose and ionizing radiation compared with vitamin E. Given that the significantly protective effect of MT on aging-or diabetes-caused pathogenesis has been extensively demonstrated using MT transgenic mouse model (Cai et al., 2004 (Cai et al., , 2005 (Cai et al., , 2006 Penkowa et al., 2004 Penkowa et al., , 2005 Fang et al., 2006; Li et al., 2006; Yang et al., 2006; Cai, 2007) , the GST-SUMO-MT may be a potential candidate to be developed for the clinical application.
In summary, we provide the first evidence that SUMOmodified MT can be highly expressed in E. coli, and its purified product can be administered in vivo to effectively protect the multiple organs against aging-, diabetes-, and ionizing radiation-related oxidative damages. There may be a limitation of the present study that we directly used the GST-SUMO-MT fusion protein, rather than a purified MT alone, to the animal model. This may be an obstacle for directly using the GST-SUMO-MT fusion protein in clinics. However, we have demonstrated clearly the high yield of the fusion protein and efficiently antioxidant function of the GST-SUMO-MT and also eliminated the possible protection of GST-SUMO in the GST-SUMO-MT fusion protein. These results suggest that large amounts of monomeric MT protein could be obtained from the fusion protein in the future, such as by hydrolysis using SUMO protease; therefore, SUMOmodified MT may become a potential candidate to be developed for the future clinical applications of MT proteins. . Whole-body radiation-induced thymus genomic DNA damage and its protection. Mice were irradiated with whole-body radiation of 7 Gy of 60 Co ␥-rays with and without 1-h preadministration of vitamin E (7 mg/kg or 16.25 mol/kg), GST-SUMO-MT-H (7 mg/kg or 156.67 nmol/kg), GST-SUMO-MT-M (3 mg/kg or 67.14 nmol/kg), GST-SUMO-MT-L (1.5 mg/kg or 33.57 nmol/kg), and GST-SUMO (7 mg/kg or 181.5 nmol/kg). Six hours after radiation, mice were sacrificed to collect the thymus to isolate and examine the genomic DNA. The agarose gel profile is the representative of three separate runs, and the damaged DNA is shown by the smear and fast-moving DNA on agarose gel. 
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